GlobeImmune (United States)
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for GlobeImmune (United States), United States, covering academic research published from 2002 to 2020. Read More.
Open Access Percentage
47%
Total
Publications
55
Total Open
Publications
26
Total
Citations
3.3K
Open Access
Percentage
47%
Total
Publications
55
Total Open
Publications
26
Total
Citations
3.3K
Breakdown
Publisher Open
13%
Both
18%
Other Platform Open
16%
Closed
53%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 23%
4
Hybrid 18%
3
No Guarantees 59%
10
Other Platform Open
Domain 95%
18
Public 21%
4
Institution 5%
1
Other Internet 5%
1
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 18 |
Europe PMC | Domain | 13 |
Figshare | Public | 4 |
Semantic Scholar | Public | 2 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 1 |
DOI | Other Internet | 1 |